Atlas Trials

Pemetrexed and Temozolomide in Treating Patients With Relapsed Primary Central Nervous System Lymphoma (PCNSL)

Clinical trial NCT01985451 · UNKNOWN

Trial details

NCT number
NCT01985451
Sponsor
Rongjie Tao
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Central Nervous System Tumors
Start date
2013-03-01
Primary completion
2015-03-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.